reported that quantitative assessment of hyperphosphorylated tau was a better predictor of cognitive decline in PART than the Braak neuroanatomical staging system, and that a quantitative measure is a better way to measure disease severity in PART. This evidence concerns the gene MAPT and Mental deterioration.